NCT04415593: High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety
- State
- Completed
- Phase
- No phase
- People
- 44 taking part
- Started
- 1 Sep 2020
- Primary completion
- 30 May 2024
- Arms
- high dose of peanut
- Results
- None posted
- 4 Jun 2020: Trial registered
- 1 Sep 2020: Trial started
- 30 Jul 2024: Trial completed